Alkali Metals Limited share price
NSE: ALKALI · ISIN INE773I01017
Key numbers
- Market cap
- ₹ 95.6 Cr
- Current price
- ₹ 93.93
- 52-week high / low
- ₹ 107 / 47
- Stock P/E
- 89.5
- Book value
- ₹ 43.9
- Dividend yield
- 1.06%
- ROCE
- 8.1%
- ROE
- 1.3%
- Debt to equity
- 0.41
- Sales growth (3 yrs)
- 2.5%
- Profit growth (3 yrs)
- -42.3%
- 1-year return
- -2.5%
About Alkali Metals Limited
Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, carbazole, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; boronic acids, and DSSC and OLED materials; and organic, inorganic, and fine chemicals. The company's products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 21 | 19 | 25 | 29 | 18 |
| Operating profit | 2 | 0 | -0 | 6 | -0 |
| Net profit | -1 | -1 | -1 | 4 | -1 |
| EPS (₹) | -1.13 | -0.90 | -1.37 | 3.94 | -0.63 |
Peers in Specialty Chemicals
Data for information only, not investment advice. Prices end of day.